Morgan Stanley raised the firm’s price target on Welltower to $107.50 from $103 and keeps an Overweight rating on the shares. Senior housing occupancy growth beat expectations in Q1 and June updates suggest further acceleration in Q2, notes the analyst, who expects “solid” Q2 results with upside risk to estimates and guidance raises from the Healthcare REITs.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WELL:
- Welltower Announces Proposed Private Placement of $750 Million of Exchangeable Senior Notes
- Welltower price target raised to $115 from $95 at KeyBanc
- Welltower price target raised to $110 from $108 at Scotiabank
- Welltower raises FY24 revenue to $4.05-$4.17 from $4.02-$4.15
- Welltower increases quarterly dividend 10% to 67c per share